Roy H. Bible - Concepedia

Author

Roy H. Bible

Also Known As

Bible, R., R Bible, R. Bible, R. H. Bible, R. H. JUN. BIBLE, R.H. Bible, ROY H. BIBLE, Roy Bible, Roy Bible, Jr., Roy H Bible

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Virginia Tech Bristol-Myers Squibb (United States)Eli Lilly (United States)Imperial College London

About

Roy H. Bible is an author at Pfizer (United States) specializing in biochemistry, natural sciences, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Natural Sciences	8	8	515
2	Medicine	6	6	535
3	Engineering	4	4	988
4	Arts	1	1	15
5	Health Sciences	1	1	32

Roy H. Bible

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Small-bandgap endohedral metallofullerenes in high yield and purity Steven Stevenson, Gary W. Rice, Tom Glass, Nature Transition Metal ChalcogenidesInorganic ChemistryEngineeringApplied PhysicsSolid-state Chemistry	1999	938
Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project John C. Lindon, Jeremy K. Nicholson, Elaine Holmes, Toxicology and Applied Pharmacology PathologyToxicology TestingContemporary IssuesEnvironmental HealthToxicology	2003	385
A stable non-classical metallofullerene family Steven Stevenson, Patrick W. Fowler, Thomas Heine, Nature Transition Metal ChalcogenidesNatural SciencesQuantum ChemistryChemistryMetal Chain Compound	2000	370
Characterization of 2‘-Deoxyadenosine Adducts Derived from 4-Oxo-2-nonenal, a Novel Product of Lipid Peroxidation Seon Hwa Lee, Diane Rindgen, Roy H. Bible, Chemical Research in Toxicology	2000	99
PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS Chyung S. Cook, Loren Berry, Roy H. Bible, Drug Metabolism and Disposition	2003	89
Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human Josh Yuan, Dai-chang Yang, Ji Y. Zhang, Drug Metabolism and Disposition	2002	53
Pharmacokinetics and Metabolism of a COX-2 Inhibitor, Valdecoxib, in Mice Ji Y. Zhang, Josh Yuan, Yue-Fen Wang, Drug Metabolism and Disposition	2003	40
Reassignment of the structures of iodonitroimidazole, its N-methyl derivatives, and related compounds Jonathan P. Dickens, Robert Dyer, Brendan J. Hamill, The Journal of Organic Chemistry Derivative (Chemistry)Molecular SciencesN-methyl DerivativesHeterocyclicBiochemistry	1981	37
Metabonomic evaluation of idiosyncrasy-like liver injury in rats cotreated with ranitidine and lipopolysaccharide Jane F. Maddox, James P. Luyendyk, Gregory N. Cosma, Toxicology and Applied Pharmacology Idiosyncrasy-like Liver InjuryHepatologyBiochemistryMedicineLiver Physiology	2005	36
Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: Mutagenic metabolites unique to potassium canrenoate Chyung S. Cook, Charles L. Hauswald, Grant L. Schoenhard, Archives of Toxicology Metabolic ProfileBiochemistryPhysiologySecondary MetabolitePotassium Canrenoate	1988	32

Page 1